XML 43 R29.htm IDEA: XBRL DOCUMENT v3.3.1.900
Quarterly Statement of Earnings Data (Unaudited)
12 Months Ended
Dec. 31, 2015
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Statement of Earnings Data (Unaudited)
Quarterly Statement of Earnings Data (Unaudited)
 
The following table presents certain quarterly statement of earnings data for the years ended December 31, 2015 and 2014. The quarterly statement of earnings data set forth below was derived from the Company’s unaudited financial statements and includes all adjustments, consisting of normal recurring adjustments, which the Company considers necessary for a fair presentation thereof. Results of operations for any particular quarter are not necessarily indicative of results of operations for a full year or predictive of future periods.
 
2015
 
2014
 
Q1
 
Q2
 
Q3
 
Q4
 
Q1
 
Q2
 
Q3 (1)
 
Q4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands, except per share data)
Net revenues
$
570,445

 
$
641,950

 
$
650,227

 
$
704,262

 
$
259,561

 
$
278,227

 
$
502,350

 
$
581,811

Earnings from continuing operations before income taxes
83,004

 
115,940

 
135,797

 
161,178

 
73,028

 
80,487

 
39,142

 
101,535

Net earnings from continuing operations 
68,755

 
90,747

 
98,279

 
124,348

 
60,046

 
67,689

 
39,120

 
79,234

Net earnings (loss) from discontinued operations

 

 

 
(1,013
)
 
68

 
483

 
(1,697
)
 
(150
)
Net earnings
68,755

 
90,747

 
98,279

 
123,335

 
60,114

 
68,172

 
37,423

 
79,084

Net earnings (loss) attributable to AmSurg Corp. common shareholders:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Continuing
18,774

 
31,411

 
40,397

 
64,310

 
17,392

 
18,771

 
(10,697
)
 
25,311

Discontinued

 

 

 
(1,001
)
 
(197
)
 
190

 
(1,376
)
 
(196
)
Net earnings (loss)
$
18,774

 
$
31,411

 
$
40,397

 
$
63,309

 
$
17,195

 
$
18,961

 
$
(12,073
)
 
$
25,115

Basic net earnings (loss) from
continuing operations per share
$
0.39

 
$
0.66

 
$
0.85

 
$
1.31

 
$
0.55

 
$
0.59

 
$
(0.23
)
 
$
0.53

Basic net earnings (loss) per share
$
0.39

 
$
0.66

 
$
0.85

 
$
1.28

 
$
0.54

 
$
0.60

 
$
(0.26
)
 
$
0.53

Diluted net earnings (loss) from continuing operations per share
$
0.39

 
$
0.65

 
$
0.83

 
$
1.26

 
$
0.54

 
$
0.58

 
$
(0.23
)
 
$
0.53

Diluted net earnings (loss) per share
$
0.39

 
$
0.65

 
$
0.83

 
$
1.24

 
$
0.54

 
$
0.59

 
$
(0.26
)
 
$
0.53

 
(1)     The results of operations for Sheridan are effective July 16, 2014. Additionally, $16.9 million of debt extinguishment costs and $25.1 million of transaction
costs were incurred during the quarter.